|
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy
|
1R21CA205644-01
|
$167,475
|
WHITESIDE, THERESA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
|
1R01CA205975-01A1
|
$386,619
|
GHAFFARI, SAGHI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-03
|
$312,341
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-03
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-02
|
$527,391
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
|
5R01CA184922-03
|
$553,684
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
4R01CA180037-04
|
$328,888
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-05
|
$394,250
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$44,764
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOM
|
ZIA CP010121-10363
|
$85,112
|
Lan, Qing
|
DCEG (NCI)
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-02
|
$311,458
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-03
|
$537,748
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia
|
1R43CA203172-01
|
$278,000
|
MU, XUEYAN
|
TEAMEDON INTERNATIONAL, LLC
|
|
A novel hematopoietic stem cell population
|
4F31CA180604-03
|
$48,576
|
BALCEREK, JOANNA
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
|
5R03CA191983-02
|
$79,500
|
LAVAU, CATHERINE
|
DUKE UNIVERSITY
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
4R00CA183914-03
|
$248,999
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
1R01CA201719-01
|
$361,499
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A Pathway of Tumor Suppression
|
4R01CA047296-28
|
$249,580
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD
|
5R44CA192601-02
|
$467,137
|
FLAIM, JOANN
|
TARGAZYME, INC.
|
|
A rapid spontaneous murine model of CN-AML
|
1R01CA196658-01A1
|
$625,379
|
GRIMES, H.
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$268,745
|
Tosato, Giovanna
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,229,987
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant signaling in acute myeloid leukemia
|
1R01CA204396-01A1
|
$459,674
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$322,076
|
Aplan, Peter
|
CCR (NCI)
|
|
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
|
1R01CA201444-01A1
|
$413,948
|
MITTELMAN, STEVEN
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$1,035,891
|
Fry, Terry
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
|
5R33CA192980-02
|
$375,858
|
SALIPANTE, STEPHEN
|
UNIVERSITY OF WASHINGTON
|
|
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
|
4R01CA180175-04
|
$344,974
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$443,953
|
Fry, Terry
|
CCR (NCI)
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$41,944
|
Kochenderfer, James
|
CCR (NCI)
|
|
Analysis of TET2 function in acute leukemia
|
1K08CA181507-01A1
|
$180,036
|
SHIH, ALAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
Barr, Frederic
|
CCR (NCI)
|
|
ARID5B and disparities of childhood leukemia
|
3U01CA176063-03S1
|
$99,152
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ARID5B and disparities of childhood leukemia
|
3U01CA176063-03S2
|
$199,999
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ARID5B and disparities of childhood leukemia
|
5U01CA176063-03
|
$365,074
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Arsenic Trioxide activated pathways in malignant cells
|
4R01CA121192-10
|
$266,285
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-02
|
$312,244
|
NAPPER, ANDREW
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
|
4R01CA163653-04
|
$323,864
|
KOPAN, RAPHAEL
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|